COLOMBIA — Colombia’s Minister of Health, Guillermo Alfonso Jaramillo, has taken a groundbreaking step in the quest for accessible HIV treatment. He has requested the…
USA — In a world often clouded by misconceptions and stereotypes, ViiV Healthcare has taken a pioneering step to illuminate the lives of those living…
BELGIUM — In a groundbreaking development, global pharmaceutical giant GSK has made a significant stride in the fight against HIV. Its majority-owned subsidiary, ViiV Healthcare,…
USA— In the latest report by PatientView, which assesses the reputation of pharmaceutical companies based on feedback from over 2,200 patient groups worldwide, Roche, ViiV…
UNITED KINGDOM— ViiV Healthcare has received a positive opinion from the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommending the…
SOUTH AFRICA – Medicines manufacturer Aspen Pharmacare recommends that African companies be given licenses to manufacture HIV prevention drugs so as to be more accessible…
USA —ViiV Healthcare is assembling a diverse coalition of consumer businesses in a new White House-backed effort to eradicate HIV by the end of the…
SWITZERLAND – GlaxoSmithKline’s ViiV Healthcare has committed to grant voluntary license on the patents for its injectable HIV prevention drug to make it more widely…
USA – Viiv Healthcare, a specialist HIV company majority-owned by GlaxoSmithKline with Pfizer and Japan’s Shionogi as shareholders, has settled a global patent infringement lawsuit…
USA – The U.S. Food and Drug Administration has approved ViiV Healthcare’s HIV treatment Cabenuva for use every two months, which means patients only need…